Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 3284 entries
View as:

Zoladex® 10.8 BC RWS

Phase: N/A Priority: Normal
NCT ID: NCT05184257 Org: User:
Start: 01/06/22 End: 12/15/23 Due: 12/15/24

Patient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan (BEAT)

Phase: N/A Priority: Normal
NCT ID: NCT05734339 Org: User:
Start: 01/19/23 End: 02/03/25 Due: 02/03/26

Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01221584 Org: User:
Start: 10/31/10 End: 03/31/11 Due: 03/31/12

AZD8848 Single Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT01560234 Org: User:
Start: 05/31/12 End: 07/31/14 Due: 07/31/15

GALLANT 2 Tesaglitazar vs. Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00252772 Org: User:
Start: 09/30/04 End: 11/30/06 Due: 11/30/07

Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet Formulation

Phase: N/A Priority: Normal
NCT ID: NCT00867685 Org: User:
Start: 03/31/09 End: 04/30/09 Due: 04/30/10

Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Phase: N/A Priority: Normal
NCT ID: NCT00121641 Org: User:
Start: 07/31/05 End: 02/28/10 Due: 02/28/11

Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128)

Phase: N/A Priority: Normal
NCT ID: NCT00424268 Org: User:
Start: 01/31/07 End: 07/31/08 Due: 07/31/09

Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

Phase: N/A Priority: Normal
NCT ID: NCT00235911 Org: User:
Start: 09/30/03 End: 12/31/06 Due: 12/31/07

Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol Fumarate

Phase: N/A Priority: Normal
NCT ID: NCT01078623 Org: User:
Start: 02/28/10 End: 09/30/10 Due: 09/30/11

Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00861016 Org: User:
Start: 10/31/05 End: 05/31/06 Due: 05/31/07

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Phase: N/A Priority: Normal
NCT ID: NCT00676338 Org: User:
Start: 11/30/08 End: 01/31/11 Due: 01/31/12

Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease

Phase: N/A Priority: Normal
NCT ID: NCT00235950 Org: User:
Start: 01/31/04 End: 03/31/06 Due: 03/31/07

A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet

Phase: N/A Priority: Normal
NCT ID: NCT02963116 Org: User:
Start: 12/20/16 End: 03/01/17 Due: 03/01/18

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06564038 Org: User:
Start: 01/30/25 End: 04/25/31 Due: 04/25/32

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase: N/A Priority: Normal
NCT ID: NCT05348577 Org: User:
Start: 03/25/22 End: 03/04/26 Due: 03/04/27

A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT04958226 Org: User:
Start: 10/15/21 End: 02/15/23 Due: 02/15/24

Non-interventional Study of Spirometry Use to Diagnose COPD (Chronic Obstructive Pulmonary Disease) and to Prescribe Treatment to COPD Patients in the Outpatient Institutions

Phase: N/A Priority: Normal
NCT ID: NCT02248909 Org: User:
Start: 11/30/14 End: 05/31/15 Due: 05/31/16

AZD6765 Oral Single Ascending Dose/Multiple Ascending Dose (SAD/MAD)

Phase: N/A Priority: Normal
NCT ID: NCT00963365 Org: User:
Start: 11/30/08 End: 03/31/10 Due: 03/31/11

Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT00930215 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

AZD1152 in Patients With Advanced Solid Malignancies-Study 1

Phase: N/A Priority: Normal
NCT ID: NCT00497731 Org: User:
Start: 05/31/05 End: 04/30/09 Due: 04/30/10

A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00384189 Org: User:
Start: 09/30/06 End: 08/31/08 Due: 08/31/09

SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT00608868 Org: User:
Start: 01/31/07 End: 01/31/09 Due: 01/31/10

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112)

Phase: N/A Priority: Normal
NCT ID: NCT00430729 Org: User:
Start: 01/31/03 End: - Due: -

Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

Phase: N/A Priority: Normal
NCT ID: NCT00241553 Org: User:
Start: 04/30/01 End: 02/28/03 Due: 02/28/04